Nur Rahman has a diverse work experience in the field of scientific research. They began their career as a Summer Research Student at the University of Toronto in 2001, and later undertook a Fourth Year Research Project at the same institution in 2002. In 2003, they returned to the University of Toronto as a Summer Research Student once again.
In 2004, Nur Rahman joined UWO as a PhD student and remained there until 2010. During this time, they gained valuable expertise in their field.
After completing their PhD, Nur Rahman worked as a Post-Doctoral Researcher at the University of Pennsylvania from 2010 to 2012.
In 2012, they joined the University of Toronto as a Research Associate and held this position until 2019. During this time, they contributed to various research projects and further established their expertise.
In 2019, Nur Rahman became a Principal Scientist at Caprion Biosciences Inc., where they played a prominent role in conducting scientific research. They left the company in 2020.
Next, they joined Nexelis in 2020 as a Senior Scientist, contributing their expertise until 2021.
Currently, Nur Rahman holds the position of Senior Scientist at Treadwell Therapeutics, Inc. which they started in November 2021.
Nur Rahman began their education in 1998 at the University of Toronto, where they pursued a Bachelor of Science (BSc) (Hons) degree in Immunology. Nur completed their undergraduate studies in 2003. Following this, they enrolled at Western University in 2004 for their Doctor of Philosophy (PhD) in Microbiology and Immunology, which they obtained in 2010. In 2013, Nur Rahman attended The Michener Institute, focusing on Clinical Research Associate. This education history showcases Nur Rahman's progression from an undergraduate degree to a PhD, and then further specialization in the field of Clinical Research.
September 1, 2022 - present
November, 2021